AMY BARLOW: Open Payments
NPI 1902861586 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 26 payments from 10 companies in 2025. Trend: 2023 $1,117 · 2024 $1,423 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $181 |
| Novo Nordisk Inc | 7 | $120 |
| Lilly USA, LLC | 2 | $111 |
| Laborie Medical Technologies Corp. | 5 | $110 |
| Exact Sciences Corporation | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: Korlym, Ozempic, ZEPBOUND, Optilume BPH Drug Coated Balloon Catheter, Cologuard Collection Kit, Kerendia, QULIPTA, OTEZLA.
Industry payments across MD — which companies pay providers there.
